PT  - JOURNAL ARTICLE
AU  - Svetlana D. Miletic Drakulic
AU  - Snezana R. Lazarevic
AU  - Ivana P. Miloradovic
AU  - Vladimir S. Jankovic
TI  - Reccurent guillain barré syndrome after COVID-19
AID  - 10.17712/nsj.2023.4.20230012
DP  - 2023 Oct 01
TA  - Neurosciences Journal
PG  - 273--276
VI  - 28
IP  - 4
4099  - http://nsj.org.sa/content/28/4/273.short
4100  - http://nsj.org.sa/content/28/4/273.full
SO  - Neurosciences (Riyadh)2023 Oct 01; 28
AB  - Coronavirus disease 19 (COVID-19) is known to manifest itself predominantly with respiratory symptoms. However, previous experiences with this disease and many scientific studies have drawn attention to its neurological manifestations. The link between COVID-19 and many neurological diseases, including Guillain Barré syndrome (GBS), has been pointed out. Although GBS is considered a monophasic disease, its relapses occur in 2–6% of cases. We present the case of a female patient with recurrent GBS caused by COVID-19. Given that 2–6% of patients experience a relapse of GBS, and that the COVID-19 pandemic is recognized as a possible trigger of the relapse, we emphasize the importance of intensive neurological monitoring for patients diagnosed with COVID-19 who have a history of GBS.